» Articles » PMID: 32574562

NAD+ Regeneration Rescues Lifespan, but Not Ataxia, in a Mouse Model of Brain Mitochondrial Complex I Dysfunction

Overview
Journal Cell Metab
Publisher Cell Press
Date 2020 Jun 24
PMID 32574562
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial complex I regenerates NAD+ and proton pumps for TCA cycle function and ATP production, respectively. Mitochondrial complex I dysfunction has been implicated in many brain pathologies including Leigh syndrome and Parkinson's disease. We sought to determine whether NAD+ regeneration or proton pumping, i.e., bioenergetics, is the dominant function of mitochondrial complex I in protection from brain pathology. We generated a mouse that conditionally expresses the yeast NADH dehydrogenase (NDI1), a single enzyme that can replace the NAD+ regeneration capability of the 45-subunit mammalian mitochondrial complex I without proton pumping. NDI1 expression was sufficient to dramatically prolong lifespan without significantly improving motor function in a mouse model of Leigh syndrome driven by the loss of NDUFS4, a subunit of mitochondrial complex I. Therefore, mitochondrial complex I activity in the brain supports organismal survival through its NAD+ regeneration capacity, while optimal motor control requires the bioenergetic function of mitochondrial complex I.

Citing Articles

AIF3 splicing variant elicits mitochondrial malfunction via the concurrent dysregulation of electron transport chain and glutathione-redox homeostasis.

Zhou M, Liu S, Wang Y, Zhang B, Zhu M, Wang J Nat Commun. 2025; 16(1):1804.

PMID: 39979311 PMC: 11842818. DOI: 10.1038/s41467-025-57081-5.


Metformin targets mitochondrial complex I to lower blood glucose levels.

Reczek C, Chakrabarty R, DAlessandro K, Sebo Z, Grant R, Gao P Sci Adv. 2024; 10(51):eads5466.

PMID: 39693440 PMC: 11654692. DOI: 10.1126/sciadv.ads5466.


Mitophagy in Cell Death Regulation: Insights into Mechanisms and Disease Implications.

Lin J, Chen X, Du Y, Li J, Guo T, Luo S Biomolecules. 2024; 14(10).

PMID: 39456203 PMC: 11506020. DOI: 10.3390/biom14101270.


Compensatory activity of the PC-ME1 metabolic axis underlies differential sensitivity to mitochondrial complex I inhibition.

Del Prado L, Jaraiz-Rodriguez M, Agro M, Zamora-Dorta M, Azpiazu N, Calleja M Nat Commun. 2024; 15(1):8682.

PMID: 39375345 PMC: 11458614. DOI: 10.1038/s41467-024-52968-1.


Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndrome.

Nakai R, Varnum S, Field R, Shi H, Giwa R, Jia W Nat Metab. 2024; 6(10):1886-1896.

PMID: 39223312 DOI: 10.1038/s42255-024-01125-5.


References
1.
Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

2.
Johnson S, Yanos M, Kayser E, Quintana A, Sangesland M, Castanza A . mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science. 2013; 342(6165):1524-8. PMC: 4055856. DOI: 10.1126/science.1244360. View

3.
Quintana A, Zanella S, Koch H, Kruse S, Lee D, Ramirez J . Fatal breathing dysfunction in a mouse model of Leigh syndrome. J Clin Invest. 2012; 122(7):2359-68. PMC: 3387817. DOI: 10.1172/JCI62923. View

4.
Iwata M, Lee Y, Yamashita T, Yagi T, Iwata S, Cameron A . The structure of the yeast NADH dehydrogenase (Ndi1) reveals overlapping binding sites for water- and lipid-soluble substrates. Proc Natl Acad Sci U S A. 2012; 109(38):15247-52. PMC: 3458368. DOI: 10.1073/pnas.1210059109. View

5.
Schildge S, Bohrer C, Beck K, Schachtrup C . Isolation and culture of mouse cortical astrocytes. J Vis Exp. 2013; (71). PMC: 3582677. DOI: 10.3791/50079. View